Introduction: serum alpha-fetoprotein (AFP) was routinely employed as a tumor marker for
screening, diagnosis, and treatment follow-up of hepatocellular carcinoma (HCC). However …

Introduction: The global incidence of hepatocellular carcinoma (HCC) is not expected to
decline significantly over the next 30 years. And although the latest gene sequencing …

BACKGROUND Hepatocellular carcinoma (HCC) accounts for 8.2% of all cancer-related
deaths worldwide. Being a vascular tumor, vascular endothelial growth factor (VEGF) plays …

Background Diabetic foot ulcer (DFU) is one of the most devastating diabetic consequences
leading to amputations. Oxidative stress, inflammation, vascular insufficiency and …

Hepatocellular carcinoma (HCC), which accounts for~ 90% of total liver cancer cases, is
considered to be the second leading cause of death globally. Tumor vasculature has been …

Aim To determine the possible association between polymorphisms of DNA repair genes,
including XRCC1 Arg194Tryp, Arg280His, and Arg399Glu, APE1 Asp148Glu, and NEIL2 …

Background Hepatocellular carcinoma (HCC) is known to be the second leading cause of
cancer-related mortality worldwide. For improving the prognosis as well as reducing the rate …

Cinnamaldehyde (CA) is a natural compound that has promising biological activity. The
current study investigates the antitumor activity of CA in thioacetamide induced …

The P18 peptide is a functional fragment of pigment epithelial-derived factor (PEDF), which
is an endogenic angiogenesis inhibitor. This study sought to determine the anti-angiogenic …

Background: Hepatocellular carcinoma (HCC) accounts for more than 80% of primary liver
cancers. Moreover, in the next 10 years, more than one million patients are expected to die …